William Richard White - 20 Oct 2021 Form 3 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Director
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol: VTYX
Transactions as of: 20 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 20 Oct 2021, 18:48:58 UTC
Previous filing: 05 Oct 2021
Next filing: 03 Nov 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VTYX	Stock Option (right to buy)							20 Oct 2021	Common Stock	152,473	$6.03	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 22, 2021.

Content

Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 22, 2021.

Remarks:

Exhibit 24 - Power of Attorney